Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 286

1.

Ectopic adiposity and cardiometabolic health in COPD.

Coats V, Després JP, Alméras N, Martin M, Sin DD, Rabasa-Lhoret R, Larose É, Tan WC, Bourbeau J, Maltais F; CanCOLD Collaborative Research Group and the Canadian Respiratory Research Network.

Int J Chron Obstruct Pulmon Dis. 2018 Oct 15;13:3331-3340. doi: 10.2147/COPD.S168963. eCollection 2018.

2.

Active mind-body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with chronic obstructive pulmonary disease.

Gendron LM, Nyberg A, Saey D, Maltais F, Lacasse Y.

Cochrane Database Syst Rev. 2018 Oct 10;10:CD012290. doi: 10.1002/14651858.CD012290.pub2. Review.

PMID:
30306545
3.

Incorporating telemedicine into the integrated care of the COPD patient a summary of an interdisciplinary workshop held in Stresa, Italy, 7-8 September 2017.

Donner CF, Raskin J, ZuWallack R, Nici L, Ambrosino N, Balbi B, Blackstock F, Casaburi R, Dreher M, Effing T, Goldstein R, Krishnan J, Lareau SC, Make BJ, Maltais F, Meek P, Morgan M, Pépin JL, Rabbito C, Rochester CL, Silverman AR, Singh S, Spruit MA, Vitacca M, Williams L.

Respir Med. 2018 Oct;143:91-102. doi: 10.1016/j.rmed.2018.09.003. Epub 2018 Sep 8. Review.

PMID:
30261999
4.

Automated O2 titration improves exercise capacity in patients with hypercapnic chronic obstructive pulmonary disease: a randomised controlled cross-over trial.

Vivodtzev I, L'Her E, Vottero G, Yankoff C, Tamisier R, Maltais F, Lellouche F, Pépin JL.

Thorax. 2018 Aug 30. pii: thoraxjnl-2018-211967. doi: 10.1136/thoraxjnl-2018-211967. [Epub ahead of print]

PMID:
30166425
5.

Test-re-test reliability of quadriceps muscle strength measures in people with more severe chronic obstructive pulmonary disease.

Nyberg A, Saey D, Martin M, Maltais F.

J Rehabil Med. 2018 Aug 22;50(8):759-764. doi: 10.2340/16501977-2354.

6.

Randomised controlled trial of adjunctive inspiratory muscle training for patients with COPD.

Charususin N, Gosselink R, Decramer M, Demeyer H, McConnell A, Saey D, Maltais F, Derom E, Vermeersch S, Heijdra YF, van Helvoort H, Garms L, Schneeberger T, Kenn K, Gloeckl R, Langer D.

Thorax. 2018 Oct;73(10):942-950. doi: 10.1136/thoraxjnl-2017-211417. Epub 2018 Jun 18.

PMID:
29914940
7.

Asthma-COPD Overlap Phenotypes and Smoking :Comparative features of asthma in smoking or non-smoking patients with an incomplete reversibility of airway obstruction.

Boulet LP, Boulay MÈ, Dérival JL, Milot J, Lepage J, Bilodeau L, Maltais F.

COPD. 2018 Apr;15(2):130-138. doi: 10.1080/15412555.2017.1395834. Epub 2018 Apr 23.

PMID:
29683758
8.

Effect of Bronchodilation, Exercise Training, and Behavior Modification on Symptoms and Physical Activity in Chronic Obstructive Pulmonary Disease.

Troosters T, Maltais F, Leidy N, Lavoie KL, Sedeno M, Janssens W, Garcia-Aymerich J, Erzen D, De Sousa D, Korducki L, Hamilton A, Bourbeau J.

Am J Respir Crit Care Med. 2018 Oct 15;198(8):1021-1032. doi: 10.1164/rccm.201706-1288OC.

PMID:
29664681
9.

Adherence to long-term oxygen therapy in patients with chronic obstructive pulmonary disease.

Gauthier A, Bernard S, Bernard E, Simard S, Maltais F, Lacasse Y.

Chron Respir Dis. 2019 Jan-Dec;16:1479972318767724. doi: 10.1177/1479972318767724. Epub 2018 Apr 9.

PMID:
29631423
10.

Exacerbation induces a microbiota shift in sputa of COPD patients.

Jubinville E, Veillette M, Milot J, Maltais F, Comeau AM, Levesque RC, Duchaine C.

PLoS One. 2018 Mar 26;13(3):e0194355. doi: 10.1371/journal.pone.0194355. eCollection 2018.

11.
12.

Home Oxygen in Chronic Obstructive Pulmonary Disease.

Lacasse Y, Tan AM, Maltais F, Krishnan JA.

Am J Respir Crit Care Med. 2018 May 15;197(10):1254-1264. doi: 10.1164/rccm.201802-0382CI.

PMID:
29547003
13.

Ventilatory support or respiratory muscle training as adjuncts to exercise in obese CPAP-treated patients with obstructive sleep apnoea: a randomised controlled trial.

Vivodtzev I, Tamisier R, Croteau M, Borel JC, Grangier A, Wuyam B, Lévy P, Minville C, Sériès F, Maltais F, Pépin JL.

Thorax. 2018 Feb 20. pii: thoraxjnl-2017-211152. doi: 10.1136/thoraxjnl-2017-211152. [Epub ahead of print]

PMID:
29463621
14.

Effect of 12 weeks of once-daily tiotropium/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive pulmonary disease.

Maltais F, O'Donnell D, Gáldiz Iturri JB, Kirsten AM, Singh D, Hamilton A, Tetzlaff K, Zhao Y, Casaburi R.

Ther Adv Respir Dis. 2018 Jan-Dec;12:1753465818755091. doi: 10.1177/1753465818755091.

15.

Effect of tiotropium on spontaneous expiratory flow-volume curves during exercise in GOLD 1-2 COPD.

Porszasz J, Carraro N, Cao R, Gore A, Ma S, Jiang T, Maltais F, Ferguson GT, O'Donnell DE, Shaikh A, Rossiter HB, Casaburi R.

Respir Physiol Neurobiol. 2018 May;251:8-15. doi: 10.1016/j.resp.2018.02.006. Epub 2018 Feb 10.

PMID:
29438808
16.

Relationship between exercise endurance and static hyperinflation in a post hoc analysis of two clinical trials in patients with COPD.

Singh S, Maltais F, Tombs L, Fahy WA, Vahdati-Bolouri M, Locantore N, Riley JH.

Int J Chron Obstruct Pulmon Dis. 2018 Jan 8;13:203-215. doi: 10.2147/COPD.S145285. eCollection 2018.

17.

Cost-effectiveness of FreeO2 in patients with chronic obstructive pulmonary disease hospitalised for acute exacerbations: analysis of a pilot study in Quebec.

Poder TG, Kouakou CRC, Bouchard PA, Tremblay V, Blais S, Maltais F, Lellouche F.

BMJ Open. 2018 Jan 23;8(1):e018835. doi: 10.1136/bmjopen-2017-018835.

18.

Cardiorespiratory and muscle oxygenation responses to low-load/high-repetition resistance exercises in COPD and healthy controls.

Nyberg A, Saey D, Martin M, Maltais F.

J Appl Physiol (1985). 2018 Apr 1;124(4):877-887. doi: 10.1152/japplphysiol.00447.2017. Epub 2017 Dec 21.

PMID:
29357500
19.

β-Blockers in COPD: A Cohort Study From the TONADO Research Program.

Maltais F, Buhl R, Koch A, Amatto VC, Reid J, Grönke L, Bothner U, Voß F, McGarvey L, Ferguson GT.

Chest. 2018 Jun;153(6):1315-1325. doi: 10.1016/j.chest.2018.01.008. Epub 2018 Jan 31.

20.

Clinical Experience with SERPINA1 DNA Sequencing to Detect Alpha-1 Antitrypsin Deficiency.

Maltais F, Gaudreault N, Racine C, Thériault S, Bossé Y.

Ann Am Thorac Soc. 2018 Feb;15(2):266-268. doi: 10.1513/AnnalsATS.201708-694RL. No abstract available.

PMID:
29182883
21.

Quadriceps muscle fat infiltration is associated with cardiometabolic risk in COPD.

Vivodtzev I, Moncharmont L, Tamisier R, Borel JC, Arbib F, Wuyam B, Lévy P, Maltais F, Ferretti G, Pépin JL.

Clin Physiol Funct Imaging. 2018 Sep;38(5):788-797. doi: 10.1111/cpf.12481. Epub 2017 Nov 3.

PMID:
29105276
22.

Work productivity loss in mild to moderate COPD: lessons learned from the CanCOLD study.

de Sousa Sena R, Ahmed S, Tan WC, Li PZ, Labonté L, Aaron SD, Benedetti A, Chapman KR, Walker B, Fitzgerald JM, Hernandez P, Maltais F, Marciniuk DD, O'Donnell DE, Sin DD, Bourbeau J; CanCOLD Collaborative Research Group and The Canadian Respiratory Research Network.

Eur Respir J. 2017 Sep 12;50(3). pii: 1701154. doi: 10.1183/13993003.01154-2017. Print 2017 Sep. No abstract available.

PMID:
28899939
23.

Global Initiative for Chronic Obstructive Lung Disease 2017 Classification and Lung Function Decline in Chronic Obstructive Pulmonary Disease.

Tan WC, Bourbeau J, Aaron SD, Zhou G, Maltais F, Hernandez P, Fitzgerald JM, Marciniuk DD, Walker BL, Sin DD.

Am J Respir Crit Care Med. 2018 Mar 1;197(5):670-673. doi: 10.1164/rccm.201706-1154LE. No abstract available.

PMID:
28858570
24.

Physical activity patterns and clusters in 1001 patients with COPD.

Mesquita R, Spina G, Pitta F, Donaire-Gonzalez D, Deering BM, Patel MS, Mitchell KE, Alison J, van Gestel AJ, Zogg S, Gagnon P, Abascal-Bolado B, Vagaggini B, Garcia-Aymerich J, Jenkins SC, Romme EA, Kon SS, Albert PS, Waschki B, Shrikrishna D, Singh SJ, Hopkinson NS, Miedinger D, Benzo RP, Maltais F, Paggiaro P, McKeough ZJ, Polkey MI, Hill K, Man WD, Clarenbach CF, Hernandes NA, Savi D, Wootton S, Furlanetto KC, Cindy Ng LW, Vaes AW, Jenkins C, Eastwood PR, Jarreta D, Kirsten A, Brooks D, Hillman DR, Sant'Anna T, Meijer K, Dürr S, Rutten EP, Kohler M, Probst VS, Tal-Singer R, Gil EG, den Brinker AC, Leuppi JD, Calverley PM, Smeenk FW, Costello RW, Gramm M, Goldstein R, Groenen MT, Magnussen H, Wouters EF, ZuWallack RL, Amft O, Watz H, Spruit MA.

Chron Respir Dis. 2017 Aug;14(3):256-269. doi: 10.1177/1479972316687207. Epub 2017 Feb 24.

25.

Effects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPD.

O'Donnell DE, Casaburi R, Frith P, Kirsten A, De Sousa D, Hamilton A, Xue W, Maltais F.

Eur Respir J. 2017 Apr 19;49(4). pii: 1601348. doi: 10.1183/13993003.01348-2016. Print 2017 Apr.

26.

Comparative prevalence of co-morbidities in smoking and non-smoking asthma patients with incomplete reversibility of airway obstruction, non-smoking asthma patients with complete reversibility of airway obstruction and COPD patients.

Nadeau M, Boulay MÈ, Milot J, Lepage J, Bilodeau L, Maltais F, Boulet LP.

Respir Med. 2017 Apr;125:82-88. doi: 10.1016/j.rmed.2017.03.005. Epub 2017 Mar 6.

PMID:
28340867
27.

Functional Tests in Chronic Obstructive Pulmonary Disease, Part 2: Measurement Properties.

Bui KL, Nyberg A, Maltais F, Saey D.

Ann Am Thorac Soc. 2017 May;14(5):785-794. doi: 10.1513/AnnalsATS.201609-734AS. Review.

PMID:
28244801
28.

Functional Tests in Chronic Obstructive Pulmonary Disease, Part 1: Clinical Relevance and Links to the International Classification of Functioning, Disability, and Health.

Bui KL, Nyberg A, Maltais F, Saey D.

Ann Am Thorac Soc. 2017 May;14(5):778-784. doi: 10.1513/AnnalsATS.201609-733AS. Review.

PMID:
28244799
29.

Ectopic fat accumulation in patients with COPD: an ECLIPSE substudy.

Martin M, Almeras N, Després JP, Coxson HO, Washko GR, Vivodtzev I, Wouters EF, Rutten E, Williams MC, Murchison JT, MacNee W, Sin DD, Maltais F.

Int J Chron Obstruct Pulmon Dis. 2017 Jan 31;12:451-460. doi: 10.2147/COPD.S124750. eCollection 2017.

30.

Novel 2-Substituted 7-Azaindole and 7-Azaindazole Analogues as Potential Antiviral Agents for the Treatment of Influenza.

Bandarage UK, Clark MP, Perola E, Gao H, Jacobs MD, Tsai A, Gillespie J, Kennedy JM, Maltais F, Ledeboer MW, Davies I, Gu W, Byrn RA, Nti Addae K, Bennett H, Leeman JR, Jones SM, O'Brien C, Memmott C, Bennani Y, Charifson PS.

ACS Med Chem Lett. 2017 Jan 18;8(2):261-265. doi: 10.1021/acsmedchemlett.6b00487. eCollection 2017 Feb 9.

31.

Analysis of nocturnal actigraphic sleep measures in patients with COPD and their association with daytime physical activity.

Spina G, Spruit MA, Alison J, Benzo RP, Calverley PMA, Clarenbach CF, Costello RW, Donaire-Gonzalez D, Dürr S, Garcia-Aymerich J, van Gestel AJR, Gramm M, Hernandes NA, Hill K, Hopkinson NS, Jarreta D, Kohler M, Kirsten AM, Leuppi JD, Magnussen H, Maltais F, Man WD, McKeough ZJ, Mesquita R, Miedinger D, Pitta F, Singh SJ, Smeenk FWJM, Tal-Singer R, Vagaggini B, Waschki B, Watz H, Wouters EFM, Zogg S, den Brinker AC.

Thorax. 2017 Aug;72(8):694-701. doi: 10.1136/thoraxjnl-2016-208900. Epub 2017 Jan 12.

32.

Multi-center, randomized, placebo-controlled trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease: a study protocol for the INOX trial.

Lacasse Y, Bernard S, Sériès F, Nguyen VH, Bourbeau J, Aaron S, Maltais F; International Nocturnal Oxygen (INOX) Research Group.

BMC Pulm Med. 2017 Jan 9;17(1):8. doi: 10.1186/s12890-016-0343-9.

33.

Three-minute constant rate step test for detecting exertional dyspnea relief after bronchodilation in COPD.

Borel B, Wilkinson-Maitland CA, Hamilton A, Bourbeau J, Perrault H, Jensen D, Maltais F.

Int J Chron Obstruct Pulmon Dis. 2016 Nov 29;11:2991-3000. eCollection 2016.

34.

Findings on Thoracic Computed Tomography Scans and Respiratory Outcomes in Persons with and without Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study.

Tan WC, Hague CJ, Leipsic J, Bourbeau J, Zheng L, Li PZ, Sin DD, Coxson HO, Kirby M, Hogg JC, Raju R, Road J, O'Donnell DE, Maltais F, Hernandez P, Cowie R, Chapman KR, Marciniuk DD, FitzGerald JM, Aaron SD; Canadian Respiratory Research Network and the CanCOLD Collaborative Research group.

PLoS One. 2016 Nov 18;11(11):e0166745. doi: 10.1371/journal.pone.0166745. eCollection 2016.

35.

Automatic Oxygen Titration During Walking in Subjects With COPD: A Randomized Crossover Controlled Study.

Lellouche F, L'Her E, Bouchard PA, Brouillard C, Maltais F.

Respir Care. 2016 Nov;61(11):1456-1464. Epub 2016 Oct 18.

36.

Automated oxygen titration and weaning with FreeO2 in patients with acute exacerbation of COPD: a pilot randomized trial.

Lellouche F, Bouchard PA, Roberge M, Simard S, L'Her E, Maltais F, Lacasse Y.

Int J Chron Obstruct Pulmon Dis. 2016 Aug 24;11:1983-90. doi: 10.2147/COPD.S112820. eCollection 2016.

37.

Adaptations in limb muscle function following pulmonary rehabilitation in patients with COPD - a review.

Nyberg A, Carvalho J, Bui KL, Saey D, Maltais F.

Rev Port Pneumol (2006). 2016 Nov - Dec;22(6):342-350. doi: 10.1016/j.rppnen.2016.06.007. Epub 2016 Aug 11. Review.

38.

Evaluation of the effects of olodaterol on exercise endurance in patients with chronic obstructive pulmonary disease: results from two 6-week crossover studies.

Maltais F, Kirsten AM, Hamilton A, De Sousa D, Voß F, Decramer M.

Respir Res. 2016 Jul 6;17(1):77. doi: 10.1186/s12931-016-0389-5.

39.

The COPD Assessment Test: Can It Discriminate Across COPD Subpopulations?

Gupta N, Pinto L, Benedetti A, Li PZ, Tan WC, Aaron SD, Chapman KR, FitzGerald JM, Hernandez P, Marciniuk DD, Maltais F, O'Donnell DE, Sin D, Walker BL, Bourbeau J; Canadian Respiratory Research Network and the CanCOLD Collaborative Research Group.

Chest. 2016 Nov;150(5):1069-1079. doi: 10.1016/j.chest.2016.06.016. Epub 2016 Jun 27.

PMID:
27364603
40.

High Oxygen Delivery to Preserve Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib. Methodology of the HOPE-IPF Study.

Ryerson CJ, Camp PG, Eves ND, Schaeffer M, Syed N, Dhillon S, Jensen D, Maltais F, O'Donnell DE, Raghavan N, Roman M, Stickland MK, Assayag D, Bourbeau J, Dion G, Fell CD, Hambly N, Johannson KA, Kalluri M, Khalil N, Kolb M, Manganas H, Morán-Mendoza O, Provencher S, Ramesh W, Rolf JD, Wilcox PG, Guenette JA.

Ann Am Thorac Soc. 2016 Sep;13(9):1640-7. doi: 10.1513/AnnalsATS.201604-267OC.

PMID:
27348402
41.

Acute Effects of Low-Load/High-Repetition Single-Limb Resistance Training in COPD.

Nyberg A, Saey D, Martin M, Maltais F.

Med Sci Sports Exerc. 2016 Dec;48(12):2353-2361.

PMID:
27337174
42.

Physiological correlates to spontaneous physical activity variability in obese patients with already treated sleep apnea syndrome.

Vivodtzev I, Mendelson M, Croteau M, Gorain S, Wuyam B, Tamisier R, Lévy P, Maltais F, Pépin JL.

Sleep Breath. 2017 Mar;21(1):61-68. doi: 10.1007/s11325-016-1368-2. Epub 2016 Jun 18.

PMID:
27318994
43.

VX-509 (Decernotinib)-Mediated CYP3A Time-Dependent Inhibition: An Aldehyde Oxidase Metabolite as a Perpetrator of Drug-Drug Interactions.

Zetterberg C, Maltais F, Laitinen L, Liao S, Tsao H, Chakilam A, Hariparsad N.

Drug Metab Dispos. 2016 Aug;44(8):1286-95. doi: 10.1124/dmd.116.071100. Epub 2016 Jun 13.

44.

A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 μg compared with tiotropium 18 μg in patients with COPD.

Feldman G, Maltais F, Khindri S, Vahdati-Bolouri M, Church A, Fahy WA, Trivedi R.

Int J Chron Obstruct Pulmon Dis. 2016 Apr 7;11:719-30. doi: 10.2147/COPD.S102494. eCollection 2016.

45.

Enhancing exercise tolerance and physical activity in COPD with combined pharmacological and non-pharmacological interventions: PHYSACTO randomised, placebo-controlled study design.

Troosters T, Bourbeau J, Maltais F, Leidy N, Erzen D, De Sousa D, Korducki L, Hamilton A.

BMJ Open. 2016 Apr 13;6(4):e010106. doi: 10.1136/bmjopen-2015-010106.

46.

Behaviour-change intervention in a multicentre, randomised, placebo-controlled COPD study: methodological considerations and implementation.

Bourbeau J, Lavoie KL, Sedeno M, De Sousa D, Erzen D, Hamilton A, Maltais F, Troosters T, Leidy N.

BMJ Open. 2016 Apr 4;6(4):e010109. doi: 10.1136/bmjopen-2015-010109.

47.

Undiagnosed Chronic Obstructive Pulmonary Disease Contributes to the Burden of Health Care Use. Data from the CanCOLD Study.

Labonté LE, Tan WC, Li PZ, Mancino P, Aaron SD, Benedetti A, Chapman KR, Cowie R, FitzGerald JM, Hernandez P, Maltais F, Marciniuk DD, O'Donnell D, Sin D, Bourbeau J; Canadian Respiratory Research Network; CanCOLD Collaborative Research Group.

Am J Respir Crit Care Med. 2016 Aug 1;194(3):285-98. doi: 10.1164/rccm.201509-1795OC.

PMID:
26836958
48.

Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement.

Puente-Maestu L, Palange P, Casaburi R, Laveneziana P, Maltais F, Neder JA, O'Donnell DE, Onorati P, Porszasz J, Rabinovich R, Rossiter HB, Singh S, Troosters T, Ward S.

Eur Respir J. 2016 Feb;47(2):429-60. doi: 10.1183/13993003.00745-2015. Epub 2016 Jan 21. Review.

49.

Bridging Lung Development with Chronic Obstructive Pulmonary Disease. Relevance of Developmental Pathways in Chronic Obstructive Pulmonary Disease Pathogenesis.

Boucherat O, Morissette MC, Provencher S, Bonnet S, Maltais F.

Am J Respir Crit Care Med. 2016 Feb 15;193(4):362-75. doi: 10.1164/rccm.201508-1518PP. Review.

PMID:
26681127
50.

Eligibility for home oxygen programs and funding across Canada.

Lacasse Y, Bernard S, Maltais F.

Can Respir J. 2015 Nov-Dec;22(6):324-30. Epub 2015 Aug 25. Review.

Supplemental Content

Loading ...
Support Center